Anticholinesterase medications inhibit the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine. By inhibiting this enzyme, these medications increase acetylcholine levels at synapses, enhancing cholinergic transmission. This mechanism is particularly useful in treating conditions like myasthenia gravis, Alzheimer's disease, and certain types of glaucoma.